Molecular volume and HBOC-induced vasoconstriction

Blood

Volumn 108, Issue 10, 2006, Pages 3231-3232

  Palmer, Andre F ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BASED OXYGEN CARRIER DERIVATIVE; HEMOGLOBIN DERIVATIVE; MACROGOL; POLYMERIZED HEMOGLOBIN; UNCLASSIFIED DRUG;

BLOOD VOLUME; ENDOTHELIUM CELL; FOOD AND DRUG ADMINISTRATION; HYPERTENSION; MICROCIRCULATION; NONHUMAN; NOTE; OXYGEN AFFINITY; OXYGENATION; POLYMERIZATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

EID: 33751171092     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-08-043083     Document Type: Note

References (5)

1. Riess JG. Oxygen carriers ("blood substitutes") - raison d'etre, chemistry and some physiology. Chem Rev. 2001;101:2797-2920.
2. Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP, Lemon DD. NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Rad Biol Med. 2004;36:685-697.
3. 2 therapeutics. Am J Physiol Heart Circ Physiol. 2003;285:H1411-H1419.
4. Arifin DR, Palmer AF. Determination of size distribution and encapsulation efficiency of liposome encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle light scattering. Biotechnol Prog. 2003;19:1798-1811.
5. Arifin DR, Palmer AF. Polymersome encapsulated hemoglobin: a novel type of oxygen carrier. Biomacromolecules. 2005;6:2172-2181.